Safety of medication options for treating pediatric esophagitis

Bibliography

• Tjon JA, Pe M, Soscia J, Mahant S. Efficacy and Safety of Proton Pump Inhibitors in the Management of Pediatric Gastroesophageal Reflux Disease. Pharmacotherapy 2013;33:956-71
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498-547
   PubMed Web of Science ®Google Scholar
• Kim J, Keininger DL, Becker S, et al. Simultaneous development of the Pediatric GERD Caregiver Impact Questionnaire (PGCIQ) in American English and American Spanish. Health Qual Life Outcomes 2005;3:5
   PubMedGoogle Scholar
• Varni JW, Bendo CB, Nurko S, et al. Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr 2015;166:85-90; e2
   PubMed Web of Science ®Google Scholar
• Vandenplas Y. Management of paediatric GERD. Nat Rev Gastroenterol Hepatol 2014;11:147-57
   PubMed Web of Science ®Google Scholar
• Okimoto E, Ishimura N, Morito Y, et al. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in same community. J Gastroenterol Hepatol 2015
   Google Scholar
• Martigne L, Delaage PH, Thomas-Delecourt F, et al. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study. Eur J Pediatr 2012;171:1767-73
   PubMed Web of Science ®Google Scholar
• Strawczynski H, McKenna RD, Nickerson GH. The Behavior of the Lower Esophageal Sphincter in Infants and Its Relationship to Gastroesophageal Regurgitation. J Pediatr 1964;64:17-23
   PubMed Web of Science ®Google Scholar
• Omari T. Gastro-oesophageal reflux disease in infants and children: new insights, developments and old chestnuts. J Pediatr Gastroenterol Nutr 2005;41(Suppl 1):S21-3
   PubMedGoogle Scholar
• van Wijk MP, Benninga MA, Davidson GP, et al. Small volumes of feed can trigger transient lower esophageal sphincter relaxation and gastroesophageal reflux in the right lateral position in infants. J Pediatr 2010;156:744-8; 8 e1
   PubMed Web of Science ®Google Scholar
• Hegar B, Dewanti NR, Kadim M, et al. Natural evolution of regurgitation in healthy infants. Acta Paediatr 2009;98:1189-93
   PubMed Web of Science ®Google Scholar
• Beaumont H, Bennink RJ, de Jong J, et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010;59:441-51
   PubMed Web of Science ®Google Scholar
• Kahrilas PJ, McColl K, Fox M, et al. The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol 2013;108:1058-64
   PubMed Web of Science ®Google Scholar
• Rohof WO, Bennink RJ, Boeckxstaens GE. Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach. Clin Gastroenterol Hepatol 2014;12:1101-7; e1
   PubMed Web of Science ®Google Scholar
• Jo YJ. Proton pump inhibitors reduce the size and acidity of the gastric Acid pocket. J Neurogastroenterol Motil 2015;21:133-4
   PubMed Web of Science ®Google Scholar
• Orenstein SR, McGowan JD. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux. J Pediatr 2008;152:310-14
   PubMed Web of Science ®Google Scholar
• Lightdale JR, Gremse DA. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 2013;131:e1684-95
   PubMed Web of Science ®Google Scholar
• Craig WR, Hanlon-Dearman A, Sinclair C, et al. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev 2004;CD003502
   Google Scholar
• Clarke P, Robinson MJ. Thickening milk feeds may cause necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2004;89:F280
   PubMed Web of Science ®Google Scholar
• Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006;166:965-71
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, De Schepper J, Verheyden S, et al. A preliminary report on the efficacy of the multicare AR-Bed in 3-week-3-month-old infants on regurgitation, associated symptoms and acid reflux. Arch Dis Child 2010;95:26-30
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Whitington PF, Orenstein DM. The infant seat as treatment for gastroesophageal reflux. N Engl J Med 1983;309:760-3
   PubMed Web of Science ®Google Scholar
• Corvaglia L, Rotatori R, Ferlini M, et al. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr 2007;151:591-6; 6 e1
   PubMed Web of Science ®Google Scholar
• van der Pol R, Smite M, Benninga MA, et al. Non-pharmacological therapies for GERD in infants and children. J Pediatr Gastroenterol Nutr 2011;53(Suppl 2):S6-8
   PubMedGoogle Scholar
• Isolauri E, Tahvanainen A, Peltola T, et al. Breast-feeding of allergic infants. J Pediatr 1999;134:27-32
   PubMed Web of Science ®Google Scholar
• Moazzez R, Bartlett D, Anggiansah A. The effect of chewing sugar-free gum on gastro-esophageal reflux. J Dent Res 2005;84:1062-5
   PubMed Web of Science ®Google Scholar
• Ward RM, Kearns GL. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013;15:119-31
   PubMed Web of Science ®Google Scholar
• Hyman PE, Garvey TQIII, Abrams CE. Tolerance to intravenous ranitidine. J Pediatr 1987;110:794-6
   PubMed Web of Science ®Google Scholar
• Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:1798-810
   PubMed Web of Science ®Google Scholar
• Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr 2000;137:800-7
   PubMed Web of Science ®Google Scholar
• Litalien C, Theoret Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet 2005;44:441-66
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20; e4
   PubMed Web of Science ®Google Scholar
• van der Pol RJ, Smits MJ, van Wijk MP, et al. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 2011;127:925-35
   PubMed Web of Science ®Google Scholar
• Gremse DA, Donnelly JR, Kukulka MJ, et al. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe. Aliment Pharmacol Ther 2004;19:1211-15
   PubMed Web of Science ®Google Scholar
• Cucchiara S, Gobio-Casali L, Balli F, et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. J Pediatr Gastroenterol Nutr 1989;8:150-6
   PubMed Web of Science ®Google Scholar
• Simeone D, Caria MC, Miele E, et al. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr 1997;25:51-5
   PubMed Web of Science ®Google Scholar
• van der Pol R, Langendam M, Benninga M, et al. Efficacy and safety of histamine-2 receptor antagonists. JAMA pediatrics 2014;168:947-54
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Izadnia F, Khan S. Gastroesophageal reflux disease in children. Gastroenterol Clin North Am 1999;28:947-69
   PubMed Web of Science ®Google Scholar
• Cucchiara S, Staiano A, Romaniello G, et al. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child 1984;59:842-7
   PubMed Web of Science ®Google Scholar
• Iacono G, Carroccio A, Montalto G, et al. [Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux]. Minerva Pediatr 1991;43:797-800
   PubMedGoogle Scholar
• Tsou VM, Young RM, Hart MH, et al. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics 1991;87:148-51
   PubMed Web of Science ®Google Scholar
• D’Souza R, Gandhi S, Fortinsky KJ, et al. Calcium carbonate intoxication in pregnancy: the return of the milk-alkali syndrome. J Obstet Gynaecol Can 2013;35:976-7
   PubMedGoogle Scholar
• Augood C, MacLennan S, Gilbert R, et al. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2003;CD002300
   Google Scholar
• Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005;59:725-9
   PubMed Web of Science ®Google Scholar
• Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics 2006;118:746-52
   PubMed Web of Science ®Google Scholar
• Tighe MP, Afzal NA, Bevan A, et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009;11:185-202
   PubMedGoogle Scholar
• Eras Z, Oguz SS, Dilmen U. Is metoclopramide safe for the premature infant? Eur Rev Med Pharmacol Sci 2013;17:1655-7
   PubMed Web of Science ®Google Scholar
• Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther 2012;35:745-67
   PubMed Web of Science ®Google Scholar
• Arguelles-Martin F, Gonzalez-Fernandez F, et al. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children. Am J Med 1989;86:73-6
   PubMed Web of Science ®Google Scholar
• Forbes D, Hodgson M, Hill R. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr 1986;5:556-9
   PubMed Web of Science ®Google Scholar
• Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987;146:156-8
   PubMed Web of Science ®Google Scholar
• Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut 1987;28:96-107
   PubMed Web of Science ®Google Scholar
• Del Piano M, Pagliarulo M, Tari R, et al. Correlation between chronic treatment with proton pump inhibitors and bacterial overgrowth in the stomach: any possible beneficial role for selected lactobacilli? J Clin Gastroenterol 2014;48(Suppl 1):S40-6
   PubMedGoogle Scholar
• Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817-20
   PubMed Web of Science ®Google Scholar
• Canani RB, Terrin G. Gastric acidity inhibitors and the risk of intestinal infections. Curr Opin Gastroenterol 2010;26:31-5
   PubMed Web of Science ®Google Scholar
• Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95
   PubMed Web of Science ®Google Scholar
• Sultan N, Nazareno J, Gregor J. Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials. Can J Gastroenterol 2008;22:761-6
   PubMed Web of Science ®Google Scholar
• Merli M, Lucidi C, Di Gregorio V, et al. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int 2015;35:362-9
   PubMed Web of Science ®Google Scholar
• Terrin G, Canani RB, Passariello A, et al. Inhibitors of gastric acid secretion drugs increase neonatal morbidity and mortality. J Matern Fetal Neonatal Med 2012;25(Suppl 4):85-7
   PubMedGoogle Scholar
• Eom CS, Jeon CY, Lim JW, et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011;183:310-19
   PubMed Web of Science ®Google Scholar
• Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-60
   PubMed Web of Science ®Google Scholar
• Herzig SJ, Doughty C, Lahoti S, et al. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia. Ann Neurol 2014;76:712-18
   PubMed Web of Science ®Google Scholar
• Ho SW, Tsai MC, Teng YH, et al. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors. BMJ open 2014;4:e006710
   PubMed Web of Science ®Google Scholar
• Johnstone J, Nerenberg K, Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther 2010;31:1165-77
   PubMed Web of Science ®Google Scholar
• Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007;167:950-5
   PubMed Web of Science ®Google Scholar
• Barkun AN, Bardou M, Pham CQ, et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 2012;107:507-20
   PubMed Web of Science ®Google Scholar
• Winter H, Kum-Nji P, Mahomedy SH, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr 2010;50:609-18
   PubMed Web of Science ®Google Scholar
• Winter H, Gunasekaran T, Tolia V, et al. Esomeprazole for the treatment of GERD in infants ages 1-11 months. J Pediatr Gastroenterol Nutr 2012;55:14-20
   PubMed Web of Science ®Google Scholar
• Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012;307:373-81
   PubMed Web of Science ®Google Scholar
• Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693-703
   PubMed Web of Science ®Google Scholar
• Turco R, Martinelli M, Miele E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010;31:754-9
   PubMed Web of Science ®Google Scholar
• Doorduyn Y, Van Den Brandhof WE, et al. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect 2006;134:617-26
   PubMed Web of Science ®Google Scholar
• Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006;117:e137-42
   PubMed Web of Science ®Google Scholar
• Terrin G, Passariello A, De Curtis M, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012;129:e40-5
   PubMed Web of Science ®Google Scholar
• Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-53
   PubMed Web of Science ®Google Scholar
• Leontiadis GI, Moayyedi P. Proton pump inhibitors and risk of bone fractures. Curr Treat Options Gastroenterol 2014;12:414-23
   PubMedGoogle Scholar
• Tjon JA, Pe M, Soscia J, Mahant S. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy 2013;33:956-71
   PubMed Web of Science ®Google Scholar
• Zipursky J, Macdonald EM, Hollands S, et al. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. PLoS Med 2014;11:e1001736
   PubMedGoogle Scholar
• Famularo G, Gasbarrone L, Minisola G. Hypomagnesemia and proton-pump inhibitors. Expert Opin Drug Saf 2013;12:709-16
   PubMed Web of Science ®Google Scholar
• Chen KP, Lee J, Mark RG, et al. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients. J Clin pharmacol 2015
   Web of Science ®Google Scholar
• Hassall E, Owen D, Kerr W, et al. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther 2011;33:829-36
   PubMed Web of Science ®Google Scholar
• Smith CH, Israel DM, Schreiber R, et al. Proton pump inhibitors for irritable infants. Can Fam Physician 2013;59:153-6
   PubMed Web of Science ®Google Scholar